date:Dec 10, 2012
h intensity sweeteners and pharmaceutical active ingredients or intermediates). For some of these products Evolva has already developed strains with commercially attractive yields. The first products other than resveratrol and vanillin could be on market in 2016.
Evolvas stevia and saffron products remain on track for launch in 2015 and 2016 respectively. Results on stevia to date confirm that Evolvas innovative and sustainable fermentation technology allows manufacturers much greater flexibili